Form 8-K - Current report:
SEC Accession No. 0001104659-21-076264
Filing Date
2021-06-03
Accepted
2021-06-03 13:55:04
Documents
1
Period of Report
2021-06-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118448d1_8k.htm 8-K 31881
  Complete submission text file 0001104659-21-076264.txt   33028
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 21992044
SIC: 2834 Pharmaceutical Preparations